Cargando…
Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome
OBJECTIVE: To evaluate the long-term effects of thrombolysis on patients with submassive pulmonary embolism (PE). METHODS: Data of 136 patients with acute submassive PE and low risk of bleeding were prospectively collected from January 2005 to October 2011 in a single medical center. Patients receiv...
Autores principales: | Mi, Yu-Hong, Liang, Ying, Lu, Yan-Hui, Li, Ya-Min, Liu, Wen-Xu, Qian, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888913/ https://www.ncbi.nlm.nih.gov/pubmed/24454324 http://dx.doi.org/10.3969/j.issn.1671-5411.2013.04.005 |
Ejemplares similares
-
Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019) -
Thrombolytic therapy in submassive pulmonary embolism
por: Özlek, Eda, et al.
Publicado: (2017) -
Submassive Pulmonary Embolism and Left Atrial Thrombus
por: Konik, Ewa, et al.
Publicado: (2018) -
Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021) -
Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2017)